Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
2.980
-0.330 (-9.97%)
At close: Mar 12, 2026, 4:00 PM EDT
3.008
+0.028 (0.94%)
After-hours: Mar 12, 2026, 7:25 PM EDT

Agenus Revenue

Agenus had revenue of $30.24M in the quarter ending September 30, 2025, with 20.40% growth. This brings the company's revenue in the last twelve months to $106.83M, down -33.41% year-over-year. In the year 2024, Agenus had annual revenue of $103.46M, down -33.81%.

Revenue (ttm)
$106.83M
Revenue Growth
-33.41%
P/S Ratio
0.95
Revenue / Employee
$338,066
Employees
316
Market Cap
101.34M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024103.46M-52.85M-33.81%
Dec 31, 2023156.31M58.29M59.47%
Dec 31, 202298.02M-197.64M-66.85%
Dec 31, 2021295.67M207.50M235.34%
Dec 31, 202088.17M-61.88M-41.24%
Dec 31, 2019150.05M113.26M307.92%
Dec 31, 201836.78M-6.09M-14.21%
Dec 31, 201742.88M20.30M89.95%
Dec 31, 201622.57M-2.24M-9.04%
Dec 31, 201524.82M17.84M255.67%
Dec 31, 20146.98M3.93M129.13%
Dec 31, 20133.05M-12.92M-80.92%
Dec 31, 201215.96M13.20M479.17%
Dec 31, 20112.76M-603.84K-17.97%
Dec 31, 20103.36M25.17K0.75%
Dec 31, 20093.33M683.36K25.78%
Dec 31, 20082.65M-2.90M-52.25%
Dec 31, 20075.55M4.86M702.20%
Dec 31, 2006692.14K62.16K9.87%
Dec 31, 2005629.98K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Codexis52.93M
Gossamer Bio44.05M
Korro Bio7.37M
Equillium4.39M
Coya Therapeutics3.99M
Inovio Pharmaceuticals182.34K
Genelux8.00K
Revenue Rankings